Search
for
Sort by
Research 631–660 of 1000+
- Index
- British Society for Dermatopathology
- Androgenic disorders
- Prostaglandin metabolism in human hair follicle
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Significance of the S100A4 Protein in Psoriasis
- Inhibition of glycosphingolipid synthesis reverses skin inflammation and hair loss in ApoE−/− mice fed western diet
- Review paper The use of reflectance confocal microscopy in selected inflammatory skin diseases
- Endocrinology & Metabolism News, August 2005
- The urine as a diagnostic key for a homozygous EGFR mutation
- Assessment of the impact of VDR polymorphisms on selected hormonal, metabolic and mineral balance markers in young women with hyperandrogenism
- Live Imaging of the Skin Immune Responses
- Dietary Therapy in Type II Diabetes Mellitus
- E.L.F. sqare waves: a new therapy for androgenetic alopecia?
- Development of a Chitosan Nanofibrillar Scaffold for Skin Repair and Regeneration
- Baicalin, a flavonoid, affects the activity of human dermal papilla cells and promotes anagen induction in mice
- Analysis of histological and microRNA profiles changes in rabbit skin development
- Abstracts
- The Rotterdam Study: 2016 objectives and design update
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Vitamin D metabolism and function in the skin
- Physiologic skin changes in pregnancy
- Extraskeletal actions of vitamin D
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Regulation of masculinization: androgen signalling for external genitalia development
- Evidence-based approach to cutaneous hyperandrogenism in women
- Anabolic-androgenic steroids and cardiovascular risk
- Obesity and the Polycystic Ovary Syndrome